Invivyd appoints Sara Cotter to Board; option for 100,000 shares

Invivyd, Inc.

Sara Cotter appointed to Board effective July 25, 2023, increasing board size from 8 to 9.
Cotter receives $40,000 annual cash retainer and nonqualified option for 100,000 shares vesting over 3 years.
Cotter is Portfolio Manager for UBS Global Biotech Lux Fund and former CEO of Levo Therapeutics.
Company advancing lead candidate VYD222; initial Phase 1 data positive and pivotal trial planned.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sara Cotter

director

IVVD · Invivyd, Inc.

Effective: 2023-07-25
Filed: July 27, 2023, 7:59 PM ET

appointed Sara Cotter as a director to fill the resulting vacancy, effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sara Cotter was appointed as director at Invivyd, Inc..

Action: appointed
Role: director

Exact text from the filing

appointed Sara Cotter as a director to fill the resulting vacancy, effective immediately

View on SEC.gov

Invivyd, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-196086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.